Autoimmune pancytopenia following allogeneic bone marrow transplantation.
A 47-year-old female developed autoimmune hemolytic anemia, autoimmune neutropenia, and autoimmune thrombocytopenia 19 months following allogeneic bone marrow transplantation for chronic myelogenous leukemia. Treatment with high-dose corticosteroids resulted in marked improvement in all three cell lines.
Klumpp
T R
TR
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston.
Caligiuri
M A
MA
Rabinowe
S N
SN
Soiffer
R J
RJ
Murray
C
C
Ritz
J
J
Caliguri
M A
MA
D001327:Autoimmune Diseases / Q000188:drug therapy / Q000209:etiology*; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000276:immunology; D005260:Female; D006789:Host vs Graft Reaction; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000601:surgery*; D008875:Middle Aged; D010198:Pancytopenia / Q000188:drug therapy / Q000209:etiology*; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000276:immunology
D011241:Prednisone